JPEO-CBRND RFI - Innovation in Biologics Manufacturing

Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) Request for Information (RFI) Innovation in Biologics Manufacturing THIS IS A REQUEST FOR INFORMATION (RFI) ONLY – This RFI is issued solely for information and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever.

All information submitted in response to this announcement is voluntary; the United States Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the United States Government. Not responding to this RFI does not preclude participation in any future RFP, if any is issued. It is the responsibility of the potential offerors to monitor sam.gov for additional information pertaining to this requirement.

The Joint Project Lead for Chemical, Biological, Radiological and Nuclear Defense (CBRND) Enabling Biotechnologies serves as the War Department’s premier program management office for investment and development of platform technologies and programs to provide medical solutions during crisis and improve preparedness for future threats.

If you have a capability or technology in the following relevant areas: Manufacturing Biologics (e.g., antibody) compatible cell free production capability that can support pre-clinical testing and potentially produce 5-10k dose lots of GMP drug substance. Innovations in biologics manufacturing process control (e.g., digital twins). Technologies to reduce biologics drug substance/product release time and/or enable real-time release. Please visit the Joint Enterprise Technology Tool (JETT) page and select “Respond to an RFI” to share your capability with us. https://jacks.jpeocbrnd.army.mil/JETT